Antiretroviral treatment in developing countries: the peril of neglecting private providers.

Ruairi Brugha, Royal College of Surgeons in Ireland

Document Type Article

This article is also available from


Action is underway to increase access to antiretroviral drugs, especially in countries with high rates of HIV

The role of private providers is largely ignored, although they are an important source of care for stigmatising diseases in many poor countries

Evidence is emerging that antiretroviral drugs are leaking into formal and informal private markets

Uncontrolled use of drugs in the private sector will lead to rapid development of HIV resistance

Countries require guidance and support from international policy makers and pharmaceutical companies to implement strategies for working with private providers